Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Classificação em ações #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Preço da ação
$3.86
Valor de mercado
$21.49M
Variação (1 dia)
-0.17%
Variação (1 ano)
-25.27%
País
JP
Negociar Human Metabolome Technologies, Inc. (6090)

Categoria

Histórico de rendimento de dividendos para Human Metabolome Technologies, Inc. (6090)
O rendimento de dividendos (TTM) da Human Metabolome Technologies, Inc. (símbolo da ação: 6090) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Human Metabolome Technologies, Inc. (6090) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH